Abstract
Objectives: Our aim was to evaluate the diagnostic value of pleural fluid TNF-α and IL-10 levels in tuberculous pleural effusion (TPE) and compare with that of ADA. Material and Methods: 70 patients were enrolled in the study. Fourteen patients had TPE, 19 patients malignant pleural effusion (MPE), 18 patients complicated parapneumonic effusion (PPE) and 19 patients had transudative pleural effusion. Results: The pleural fluid TNF-α levels were significantly higher in TPE than MPE and transudates. There was no significant difference in pleural fluid IL-10 levels between groups. Among exudative effusions, TNF-α was significantly higher in tuberculous group, while there was no difference in IL-10 levels between tuberculous and nontuberculous group. The pleural fluid ADA levels were significantly higher in TPE than other groups. ROC analysis was performed and the optimal cut-off points of TNF-α and ADA were 13.3 pg/mL and 41.5 U/L, respectively. The sensitivity of TNF-α was 71% and specificity was 66% in the diagnosis of TPE. In contrast, the sensitivity and specifity of ADA was 78% and 86% respectively. Conclusion: TNF-α is a useful marker in the diagnosis of TPE and IL-10 has no diagnostic value. However, the sensitivity and specifity of TNF-α is lower than that of ADA.
Keywords: Tuberculosis, pleural effusion, TNF-α, IL-10
Current Medicinal Chemistry
Title: The Comparison of Pleural Fluid TNF-α and IL-10 Levels with ADA in Tuberculous Pleural Effusion
Volume: 17 Issue: 19
Author(s): A. Ciledag, A. Kaya, S. Erol, E. Sen, G. Celik, S. Cesur, Y. Fidan and S. Kinikli
Affiliation:
Keywords: Tuberculosis, pleural effusion, TNF-α, IL-10
Abstract: Objectives: Our aim was to evaluate the diagnostic value of pleural fluid TNF-α and IL-10 levels in tuberculous pleural effusion (TPE) and compare with that of ADA. Material and Methods: 70 patients were enrolled in the study. Fourteen patients had TPE, 19 patients malignant pleural effusion (MPE), 18 patients complicated parapneumonic effusion (PPE) and 19 patients had transudative pleural effusion. Results: The pleural fluid TNF-α levels were significantly higher in TPE than MPE and transudates. There was no significant difference in pleural fluid IL-10 levels between groups. Among exudative effusions, TNF-α was significantly higher in tuberculous group, while there was no difference in IL-10 levels between tuberculous and nontuberculous group. The pleural fluid ADA levels were significantly higher in TPE than other groups. ROC analysis was performed and the optimal cut-off points of TNF-α and ADA were 13.3 pg/mL and 41.5 U/L, respectively. The sensitivity of TNF-α was 71% and specificity was 66% in the diagnosis of TPE. In contrast, the sensitivity and specifity of ADA was 78% and 86% respectively. Conclusion: TNF-α is a useful marker in the diagnosis of TPE and IL-10 has no diagnostic value. However, the sensitivity and specifity of TNF-α is lower than that of ADA.
Export Options
About this article
Cite this article as:
Ciledag A., Kaya A., Erol S., Sen E., Celik G., Cesur S., Fidan Y. and Kinikli S., The Comparison of Pleural Fluid TNF-α and IL-10 Levels with ADA in Tuberculous Pleural Effusion, Current Medicinal Chemistry 2010; 17 (19) . https://dx.doi.org/10.2174/092986710791233652
DOI https://dx.doi.org/10.2174/092986710791233652 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Delivery Systems for Birch-bark Triterpenoids and their Derivatives in Anticancer Research
Current Medicinal Chemistry Approaches for Developing Novel Microtubule Targeting Agents (MTAs) for Therapeutic Exploitation
Current Pharmaceutical Design Chalcones in Cancer: Understanding their Role in Terms of QSAR
Current Medicinal Chemistry Synthesis and Anticancer Activity of Some 2-[3/4-(2-Substituted Phenyl-2- oxoethoxy)benzylidene]-6-substituted-2,3-dihydro-1H-inden-1-one Derivatives
Letters in Drug Design & Discovery Modulation of Mast Cell and Basophil Functions by Benzene Metabolites
Current Pharmaceutical Design Novel Therapeutic Options in Metastatic Renal Cancer – Review and Post ASCO 2007 Update
Reviews on Recent Clinical Trials Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities
Mini-Reviews in Medicinal Chemistry Nanoparticulate Drug Delivery Sytem for Cancer Therapy: Oppourtunities and Challenges
Recent Patents on Nanomedicine Recent Advances in Biological Strategies for Targeted Drug Delivery
Cardiovascular & Hematological Disorders-Drug Targets The Role of IRF1 and IRF2 Transcription Factors in Leukaemogenesis
Current Gene Therapy The Nature of Immunological Reaction in the Peripheral Airways of Cigarette Smokers
Current Respiratory Medicine Reviews Simple C-2-Substituted Quinolines and their Anticancer Activity
Letters in Drug Design & Discovery The Purinome, a Complex Mix of Drug and Toxicity Targets
Current Topics in Medicinal Chemistry G-Quadruplex Interacting Agents Targeting the Telomeric G-Overhang Are More than Simple Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Current Pharmaceutical Biotechnology Non Smoking for Successful Aging: Therapeutic Perspectives
Current Pharmaceutical Design Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem
Current Pharmacogenomics and Personalized Medicine Development of Small-Molecule PUMA Inhibitors for Mitigating Radiation-Induced Cell Death
Current Topics in Medicinal Chemistry Research Progress on the Antitumor Effects of Rhein: Literature Review
Anti-Cancer Agents in Medicinal Chemistry CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets